Perry C Siatis sold $5.8M of ABBV
EVP, GC AND SECRETARY at AbbVie Inc.. 27,900 shares at an average of $208.69, traded Feb 28, 2025, filed Mar 4, 2025.
Score components
- +15RoleOfficer
- +25Trade size$5.8M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-006578, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 28, 2025 | FTax withholding Common Stock, $0.01 par value10b5-1 | -7,870 | $205.02 | $1.6M | 14,511 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -2,718 | $205.38 | $558k | 11,793 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -6,811 | $206.62 | $1.4M | 4,982 | Mar 4, 2025 |
| Feb 28, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -363 | $207.19 | $75k | 4,619 | Mar 4, 2025 |
| Mar 3, 2025 | MOption exercise Common Stock, $0.01 par value10b5-1 | +2,918 | $144.54 | $422k | 7,537 | Mar 4, 2025 |
| Mar 3, 2025 | MOption exercise Common Stock, $0.01 par value10b5-1 | +7,315 | $149.62 | $1.1M | 14,852 | Mar 4, 2025 |
| Mar 3, 2025 | MOption exercise Common Stock, $0.01 par value10b5-1 | +7,775 | $175.28 | $1.4M | 22,627 | Mar 4, 2025 |
| Mar 3, 2025 | SOpen-market sale Common Stock, $0.01 par value10b5-1 | -18,008 | $210.00 | $3.8M | 4,619 | Mar 4, 2025 |
| Mar 3, 2025 | DDisposition to issuer Option (Right to buy)derivative10b5-1 | -2,918 | $144.54 | $422k | 0 | Mar 4, 2025 |
| Mar 3, 2025 | DDisposition to issuer Option (Right to buy)derivative10b5-1 | -7,315 | $149.62 | $1.1M | 7,314 | Mar 4, 2025 |
| Mar 3, 2025 | DDisposition to issuer Option (Right to buy)derivative10b5-1 | -7,775 | $175.28 | $1.4M | 15,549 | Mar 4, 2025 |
Related signals
Other insiders at AbbVie Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | ABBVsell AbbVie Inc. | Jeffrey Ryan Stewart EVP, CHIEF COMMERCIAL OFFICER | $12M 58,832 shares | -52% | |
| 82Strong | AbbVie Inc. | Scott T Reents EVP, CHIEF FINANCIAL OFFICER | $3.7M 17,644 shares | -60% | |
| 60Notable | AbbVie Inc. | Richard A Gonzalez director | $20M 98,628 shares | -20% | |
| 55Moderate | AbbVie Inc. | Timothy J. Richmond EVP, CHIEF HR OFFICER | $4.5M 21,250 shares | -78% | |
| 40Moderate | AbbVie Inc. | Timothy J. Richmond EVP, CHIEF HR OFFICER | $6.1M 29,917 shares | -58% | |
| 70Notable | AbbVie Inc. | Kevin K Buckbee SVP, CONTROLLER | $3.9M 18,944 shares | -124% | |
| 40Moderate | AbbVie Inc. | Perry C Siatis EVP, GC AND SECRETARY | $1.1M 5,778 shares | -21% | |
| 19Weak | ABBVsell AbbVie Inc. | Kevin K Buckbee SVP, CONTROLLER | $310k 1,800 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.